Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00051194 · ClinicalTrials.gov registry record · Phase 2
A 6-week Safety & Efficacy Study of Combination Intraocular Pressure-lowering Therapy in Patients With Open-angle Glaucoma or Ocular Hypertension
A Phase 2 study, sponsored by Alcon Research.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00051194: Completed Phase 2 study, sponsored by Alcon Research.
NCT00051194 is a Phase 2 study that has completed, run by Alcon Research. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00051194, a Phase 2 study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
To compare the intraocular pressure(IOP)-lowering efficacy of morning or evening instillations of a combination IOP-lowering therapy in patients with open-angle glaucoma or ocular hypertension.
Interventions
- DRUG Combination IOP Lowering Therapy
Trial Details
| Field | Value |
|---|---|
| Start Date | 2002-09 |
| Est. Completion | 2003-07 |
| Phase | Phase 2 |
What the finished NCT00051194 record still lists
NCT00051194 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Combination IOP Lowering Therapy is the first listed.
NCT00051194 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00051194 about?
NCT00051194 is a clinical study titled "A 6-week Safety & Efficacy Study of Combination Intraocular Pressure-lowering Therapy in Patients With Open-angle Glaucoma or Ocular Hypertension". To compare the intraocular pressure(IOP)-lowering efficacy of morning or evening instillations of a combination IOP-lowering therapy in patients with open-angle glaucoma or ocular hypertension.
What is the current status of trial NCT00051194?
This trial is currently completed. It is a Phase 2 study. The study started on 2002-09. Estimated completion is 2003-07.
What interventions are being tested in trial NCT00051194?
The interventions under investigation include: Combination IOP Lowering Therapy (DRUG).
Who is sponsoring clinical trial NCT00051194?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia